|
Jun 10
|
GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary Cholangitis
|
|
Apr 25
|
GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023)
|
|
Jan 15
|
GENFIT Announces 2024 Financial Calendar
|
|
Jan 11
|
GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
|